EcoDrugPlus

Glutamate Receptor, Ionotropic, N-Methyl-D-Aspartate 3bb

Ensembl ID : ENSMAMG00000006197
Gene Symbol: GRIN3BB
2 Cross references
222 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 1a

Ensembl ID : ENSMAMG00000013071
Gene Symbol: GRIK1A
2 Cross references
245 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 5

Ensembl ID : ENSMAMG00000004762
Gene Symbol: GRIK5
2 Cross references
232 Possible Orthologues:

Glutamate Receptor, Metabotropic 2a

Ensembl ID : ENSMAMG00000023942
Gene Symbol: GRM2A
2 Cross references
206 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSMAMG00000017406
Gene Symbol: GRM2B
3 Cross references
206 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSMAMG00000008905
Gene Symbol: GRM3
3 Cross references
215 Possible Orthologues:

Glutamate Receptor, Metabotropic 4

Ensembl ID : ENSMAMG00000024171
Gene Symbol: GRM4
2 Cross references
196 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSMAMG00000013018
Gene Symbol: GRM5A
3 Cross references
211 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSMAMG00000006586
Gene Symbol: GRM5B
3 Cross references
216 Possible Orthologues:

Glutaminase B

Ensembl ID : ENSMAMG00000010625
Gene Symbol: GLSB
2 Cross references
230 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSMAMG00000022523
Gene Symbol: LOC113127166
3 Cross references
228 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSMAMG00000004699
Gene Symbol: GSK3AB
3 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).